2.37
1 yrs 3 m
0.5%
92.45 Crs
8.46
Mid Growth
SIP 1000 & Lumpsum 5000
sector funds
Anandha Padmanabhan Anjeneyan,Utsav Mehta,Sharma Vivek
06-Dec-24
NA
The primary investment objective of the scheme is to seek to generate consistent returns by predominantly investing in equity and equity related securities of pharmaceutical and healthcare companies.
Investors understand that their principal will be at very high risk